TITLE
Interaction of CDCP1 with HER2 enhances HER2-driven tumorigenesis and promotes trastuzumab resistance in breast cancer

ORGANISM
Homo sapiens

SUMMARY
Our findings demonstrate that CDCP1 is a novel modulator of HER2 signalling, and a biomarker for the stratification of breast cancer patients with poor prognosis

DESIGN
GEP analysis of human breast cancer cell lines SKBR3 overexpressing CDCP1 and control.

PLATFORM
GPL10558 Illumina HumanHT-12 V4.0 expression beadchip

CITATIONS
25892239

